CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Aging population
3.4.1.2. Surge in demand for non-invasive and minimally invasive treatments
3.4.1.3. Initiatives by government and non-government organizations
3.4.1.4. Increase in prevalence of neurological disorders
3.4.2. Restraints
3.4.2.1. High cost of neurology devices
3.4.2.2. Lack of skilled professionals
3.4.2.3. Stringent regulatory frameworks
3.4.3. Opportunities
3.4.3.1. Technological advancement
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: NEUROLOGY DEVICES MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Neurostimulation Devices
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.2.4. Neurostimulation Devices Neurology Devices Market by Device type
4.2.4.1. Spinal Cord Stimulators Market size and forecast, by region
4.2.4.2. Deep Brain Stimulators Market size and forecast, by region
4.2.4.3. Sacral Nerve Stimulators Market size and forecast, by region
4.2.4.4. Vagus Nerve Stimulators Market size and forecast, by region
4.2.4.5. Others Market size and forecast, by region
4.3. Neurosurgery Devices
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.3.4. Neurosurgery Devices Neurology Devices Market by Device type
4.3.4.1. Neuroendoscopy Market size and forecast, by region
4.3.4.2. neurosurgery navigations Market size and forecast, by region
4.4. Interventional Neurology Devices
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.4.4. Interventional Neurology Devices Neurology Devices Market by Device type
4.4.4.1. Embolization Devices Market size and forecast, by region
4.4.4.2. Revascularization Devices Market size and forecast, by region
4.4.4.3. Thrombectomy Devices Market size and forecast, by region
4.4.4.4. Embolic Protection Devices Market size and forecast, by region
4.4.4.5. Accessory Devices Market size and forecast, by region
4.5. Cerebrospinal fluid management devices
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
4.5.4. Cerebrospinal fluid management devices Neurology Devices Market by Device type
4.5.4.1. CSF shunts Market size and forecast, by region
4.5.4.2. External drainage system Market size and forecast, by region
4.6. Others
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market share analysis by country
CHAPTER 5: NEUROLOGY DEVICES MARKET, BY END USER
5.1. Overview
5.1.1. Market size and forecast
5.2. Hospitals
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Ambulatory surgery centers
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Others
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
CHAPTER 6: NEUROLOGY DEVICES MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast By Region
6.2. North America
6.2.1. Key trends and opportunities
6.2.2. Market size and forecast, by Product
6.2.2.1. North America Neurostimulation Devices Neurology Devices Market by Device type
6.2.2.2. North America Neurosurgery Devices Neurology Devices Market by Device type
6.2.2.3. North America Interventional Neurology Devices Neurology Devices Market by Device type
6.2.2.4. North America Cerebrospinal fluid management devices Neurology Devices Market by Device type
6.2.3. Market size and forecast, by End User
6.2.4. Market size and forecast, by country
6.2.4.1. U.S.
6.2.4.1.1. Key market trends, growth factors and opportunities
6.2.4.1.2. Market size and forecast, by Product
6.2.4.1.3. Market size and forecast, by End User
6.2.4.2. Canada
6.2.4.2.1. Key market trends, growth factors and opportunities
6.2.4.2.2. Market size and forecast, by Product
6.2.4.2.3. Market size and forecast, by End User
6.2.4.3. Mexico
6.2.4.3.1. Key market trends, growth factors and opportunities
6.2.4.3.2. Market size and forecast, by Product
6.2.4.3.3. Market size and forecast, by End User
6.3. Europe
6.3.1. Key trends and opportunities
6.3.2. Market size and forecast, by Product
6.3.2.1. Europe Neurostimulation Devices Neurology Devices Market by Device type
6.3.2.2. Europe Neurosurgery Devices Neurology Devices Market by Device type
6.3.2.3. Europe Interventional Neurology Devices Neurology Devices Market by Device type
6.3.2.4. Europe Cerebrospinal fluid management devices Neurology Devices Market by Device type
6.3.3. Market size and forecast, by End User
6.3.4. Market size and forecast, by country
6.3.4.1. Germany
6.3.4.1.1. Key market trends, growth factors and opportunities
6.3.4.1.2. Market size and forecast, by Product
6.3.4.1.3. Market size and forecast, by End User
6.3.4.2. France
6.3.4.2.1. Key market trends, growth factors and opportunities
6.3.4.2.2. Market size and forecast, by Product
6.3.4.2.3. Market size and forecast, by End User
6.3.4.3. UK
6.3.4.3.1. Key market trends, growth factors and opportunities
6.3.4.3.2. Market size and forecast, by Product
6.3.4.3.3. Market size and forecast, by End User
6.3.4.4. Italy
6.3.4.4.1. Key market trends, growth factors and opportunities
6.3.4.4.2. Market size and forecast, by Product
6.3.4.4.3. Market size and forecast, by End User
6.3.4.5. Spain
6.3.4.5.1. Key market trends, growth factors and opportunities
6.3.4.5.2. Market size and forecast, by Product
6.3.4.5.3. Market size and forecast, by End User
6.3.4.6. Rest of Europe
6.3.4.6.1. Key market trends, growth factors and opportunities
6.3.4.6.2. Market size and forecast, by Product
6.3.4.6.3. Market size and forecast, by End User
6.4. Asia-Pacific
6.4.1. Key trends and opportunities
6.4.2. Market size and forecast, by Product
6.4.2.1. Asia-Pacific Neurostimulation Devices Neurology Devices Market by Device type
6.4.2.2. Asia-Pacific Neurosurgery Devices Neurology Devices Market by Device type
6.4.2.3. Asia-Pacific Interventional Neurology Devices Neurology Devices Market by Device type
6.4.2.4. Asia-Pacific Cerebrospinal fluid management devices Neurology Devices Market by Device type
6.4.3. Market size and forecast, by End User
6.4.4. Market size and forecast, by country
6.4.4.1. China
6.4.4.1.1. Key market trends, growth factors and opportunities
6.4.4.1.2. Market size and forecast, by Product
6.4.4.1.3. Market size and forecast, by End User
6.4.4.2. Japan
6.4.4.2.1. Key market trends, growth factors and opportunities
6.4.4.2.2. Market size and forecast, by Product
6.4.4.2.3. Market size and forecast, by End User
6.4.4.3. India
6.4.4.3.1. Key market trends, growth factors and opportunities
6.4.4.3.2. Market size and forecast, by Product
6.4.4.3.3. Market size and forecast, by End User
6.4.4.4. Australia
6.4.4.4.1. Key market trends, growth factors and opportunities
6.4.4.4.2. Market size and forecast, by Product
6.4.4.4.3. Market size and forecast, by End User
6.4.4.5. South Korea
6.4.4.5.1. Key market trends, growth factors and opportunities
6.4.4.5.2. Market size and forecast, by Product
6.4.4.5.3. Market size and forecast, by End User
6.4.4.6. Rest of Asia-Pacific
6.4.4.6.1. Key market trends, growth factors and opportunities
6.4.4.6.2. Market size and forecast, by Product
6.4.4.6.3. Market size and forecast, by End User
6.5. LAMEA
6.5.1. Key trends and opportunities
6.5.2. Market size and forecast, by Product
6.5.2.1. LAMEA Neurostimulation Devices Neurology Devices Market by Device type
6.5.2.2. LAMEA Neurosurgery Devices Neurology Devices Market by Device type
6.5.2.3. LAMEA Interventional Neurology Devices Neurology Devices Market by Device type
6.5.2.4. LAMEA Cerebrospinal fluid management devices Neurology Devices Market by Device type
6.5.3. Market size and forecast, by End User
6.5.4. Market size and forecast, by country
6.5.4.1. Brazil
6.5.4.1.1. Key market trends, growth factors and opportunities
6.5.4.1.2. Market size and forecast, by Product
6.5.4.1.3. Market size and forecast, by End User
6.5.4.2. Saudi Arabia
6.5.4.2.1. Key market trends, growth factors and opportunities
6.5.4.2.2. Market size and forecast, by Product
6.5.4.2.3. Market size and forecast, by End User
6.5.4.3. South Africa
6.5.4.3.1. Key market trends, growth factors and opportunities
6.5.4.3.2. Market size and forecast, by Product
6.5.4.3.3. Market size and forecast, by End User
6.5.4.4. Rest of LAMEA
6.5.4.4.1. Key market trends, growth factors and opportunities
6.5.4.4.2. Market size and forecast, by Product
6.5.4.4.3. Market size and forecast, by End User
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top player positioning, 2021
CHAPTER 8: COMPANY PROFILES
8.1. Integra Lifesciences
8.1.1. Company overview
8.1.2. Key Executives
8.1.3. Company snapshot
8.1.4. Operating business segments
8.1.5. Product portfolio
8.1.6. Business performance
8.1.7. Key strategic moves and developments
8.2. B.Braun SE
8.2.1. Company overview
8.2.2. Key Executives
8.2.3. Company snapshot
8.2.4. Operating business segments
8.2.5. Product portfolio
8.2.6. Business performance
8.3. Medtronic plc
8.3.1. Company overview
8.3.2. Key Executives
8.3.3. Company snapshot
8.3.4. Operating business segments
8.3.5. Product portfolio
8.3.6. Business performance
8.3.7. Key strategic moves and developments
8.4. Natus Medical Inc.
8.4.1. Company overview
8.4.2. Key Executives
8.4.3. Company snapshot
8.4.4. Operating business segments
8.4.5. Product portfolio
8.4.6. Key strategic moves and developments
8.5. Stryker Corporation
8.5.1. Company overview
8.5.2. Key Executives
8.5.3. Company snapshot
8.5.4. Operating business segments
8.5.5. Product portfolio
8.5.6. Business performance
8.5.7. Key strategic moves and developments
8.6. Boston Scientific Corporation
8.6.1. Company overview
8.6.2. Key Executives
8.6.3. Company snapshot
8.6.4. Operating business segments
8.6.5. Product portfolio
8.6.6. Business performance
8.6.7. Key strategic moves and developments
8.7. Abbott Laboratories
8.7.1. Company overview
8.7.2. Key Executives
8.7.3. Company snapshot
8.7.4. Operating business segments
8.7.5. Product portfolio
8.7.6. Business performance
8.7.7. Key strategic moves and developments
8.8. LivaNova PLC
8.8.1. Company overview
8.8.2. Key Executives
8.8.3. Company snapshot
8.8.4. Operating business segments
8.8.5. Product portfolio
8.8.6. Business performance
8.8.7. Key strategic moves and developments
8.9. Zimmer Biomet Holding Inc.
8.9.1. Company overview
8.9.2. Key Executives
8.9.3. Company snapshot
8.9.4. Operating business segments
8.9.5. Product portfolio
8.9.6. Business performance
8.9.7. Key strategic moves and developments
8.10. Johnson & Johnson
8.10.1. Company overview
8.10.2. Key Executives
8.10.3. Company snapshot
8.10.4. Operating business segments
8.10.5. Product portfolio
8.10.6. Business performance
TABLE 01. GLOBAL NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 02. NEUROLOGY DEVICES MARKET FOR NEUROSTIMULATION DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 03. GLOBAL NEUROSTIMULATION DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 04. NEUROLOGY DEVICES MARKET FOR SPINAL CORD STIMULATORS, BY REGION, 2021-2031 ($MILLION)
TABLE 05. NEUROLOGY DEVICES MARKET FOR DEEP BRAIN STIMULATORS, BY REGION, 2021-2031 ($MILLION)
TABLE 06. NEUROLOGY DEVICES MARKET FOR SACRAL NERVE STIMULATORS, BY REGION, 2021-2031 ($MILLION)
TABLE 07. NEUROLOGY DEVICES MARKET FOR VAGUS NERVE STIMULATORS, BY REGION, 2021-2031 ($MILLION)
TABLE 08. NEUROLOGY DEVICES MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 09. NEUROLOGY DEVICES MARKET FOR NEUROSURGERY DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 10. GLOBAL NEUROSURGERY DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 11. NEUROLOGY DEVICES MARKET FOR NEUROENDOSCOPY, BY REGION, 2021-2031 ($MILLION)
TABLE 12. NEUROLOGY DEVICES MARKET FOR NEUROSURGERY NAVIGATIONS, BY REGION, 2021-2031 ($MILLION)
TABLE 13. NEUROLOGY DEVICES MARKET FOR INTERVENTIONAL NEUROLOGY DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 14. GLOBAL INTERVENTIONAL NEUROLOGY DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 15. NEUROLOGY DEVICES MARKET FOR EMBOLIZATION DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 16. NEUROLOGY DEVICES MARKET FOR REVASCULARIZATION DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 17. NEUROLOGY DEVICES MARKET FOR THROMBECTOMY DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 18. NEUROLOGY DEVICES MARKET FOR EMBOLIC PROTECTION DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 19. NEUROLOGY DEVICES MARKET FOR ACCESSORY DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 20. NEUROLOGY DEVICES MARKET FOR CEREBROSPINAL FLUID MANAGEMENT DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 21. GLOBAL CEREBROSPINAL FLUID MANAGEMENT DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 22. NEUROLOGY DEVICES MARKET FOR CSF SHUNTS, BY REGION, 2021-2031 ($MILLION)
TABLE 23. NEUROLOGY DEVICES MARKET FOR EXTERNAL DRAINAGE SYSTEM, BY REGION, 2021-2031 ($MILLION)
TABLE 24. NEUROLOGY DEVICES MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 25. GLOBAL NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 26. NEUROLOGY DEVICES MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
TABLE 27. NEUROLOGY DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2021-2031 ($MILLION)
TABLE 28. NEUROLOGY DEVICES MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 29. NEUROLOGY DEVICES MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 30. NORTH AMERICA NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 31. NORTH AMERICA NEUROSTIMULATION DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 32. NORTH AMERICA NEUROSURGERY DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 33. NORTH AMERICA INTERVENTIONAL NEUROLOGY DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 34. NORTH AMERICA CEREBROSPINAL FLUID MANAGEMENT DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 35. NORTH AMERICA NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 36. NORTH AMERICA NEUROLOGY DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 37. U.S. NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 38. U.S. NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 39. CANADA NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 40. CANADA NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 41. MEXICO NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 42. MEXICO NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 43. EUROPE NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 44. EUROPE NEUROSTIMULATION DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 45. EUROPE NEUROSURGERY DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 46. EUROPE INTERVENTIONAL NEUROLOGY DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 47. EUROPE CEREBROSPINAL FLUID MANAGEMENT DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 48. EUROPE NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 49. EUROPE NEUROLOGY DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 50. GERMANY NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 51. GERMANY NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 52. FRANCE NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 53. FRANCE NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 54. UK NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 55. UK NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 56. ITALY NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 57. ITALY NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 58. SPAIN NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 59. SPAIN NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 60. REST OF EUROPE NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 61. REST OF EUROPE NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 62. ASIA-PACIFIC NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 63. ASIA-PACIFIC NEUROSTIMULATION DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 64. ASIA-PACIFIC NEUROSURGERY DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 65. ASIA-PACIFIC INTERVENTIONAL NEUROLOGY DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 66. ASIA-PACIFIC CEREBROSPINAL FLUID MANAGEMENT DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 67. ASIA-PACIFIC NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 68. ASIA-PACIFIC NEUROLOGY DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 69. CHINA NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 70. CHINA NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 71. JAPAN NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 72. JAPAN NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 73. INDIA NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 74. INDIA NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 75. AUSTRALIA NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 76. AUSTRALIA NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 77. SOUTH KOREA NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 78. SOUTH KOREA NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 79. REST OF ASIA-PACIFIC NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 80. REST OF ASIA-PACIFIC NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 81. LAMEA NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 82. LAMEA NEUROSTIMULATION DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 83. LAMEA NEUROSURGERY DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 84. LAMEA INTERVENTIONAL NEUROLOGY DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 85. LAMEA CEREBROSPINAL FLUID MANAGEMENT DEVICES NEUROLOGY DEVICES MARKET, BY DEVICE TYPE, 2021-2031 ($MILLION)
TABLE 86. LAMEA NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 87. LAMEA NEUROLOGY DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 88. BRAZIL NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 89. BRAZIL NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 90. SAUDI ARABIA NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 91. SAUDI ARABIA NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 92. SOUTH AFRICA NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 93. SOUTH AFRICA NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 94. REST OF LAMEA NEUROLOGY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 95. REST OF LAMEA NEUROLOGY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 96. INTEGRA LIFESCIENCES: KEY EXECUTIVES
TABLE 97. INTEGRA LIFESCIENCES: COMPANY SNAPSHOT
TABLE 98. INTEGRA LIFESCIENCES: PRODUCT SEGMENTS
TABLE 99. INTEGRA LIFESCIENCES: PRODUCT PORTFOLIO
TABLE 100. INTEGRA LIFESCIENCES: KEY STRATERGIES
TABLE 101. B.BRAUN SE: KEY EXECUTIVES
TABLE 102. B.BRAUN SE: COMPANY SNAPSHOT
TABLE 103. B.BRAUN SE: PRODUCT SEGMENTS
TABLE 104. B.BRAUN SE: PRODUCT PORTFOLIO
TABLE 105. MEDTRONIC PLC: KEY EXECUTIVES
TABLE 106. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 107. MEDTRONIC PLC: PRODUCT SEGMENTS
TABLE 108. MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 109. MEDTRONIC PLC: KEY STRATERGIES
TABLE 110. NATUS MEDICAL INC.: KEY EXECUTIVES
TABLE 111. NATUS MEDICAL INC.: COMPANY SNAPSHOT
TABLE 112. NATUS MEDICAL INC.: SERVICE SEGMENTS
TABLE 113. NATUS MEDICAL INC.: PRODUCT PORTFOLIO
TABLE 114. NATUS MEDICAL INC.: KEY STRATERGIES
TABLE 115. STRYKER CORPORATION: KEY EXECUTIVES
TABLE 116. STRYKER CORPORATION: COMPANY SNAPSHOT
TABLE 117. STRYKER CORPORATION: PRODUCT SEGMENTS
TABLE 118. STRYKER CORPORATION: PRODUCT PORTFOLIO
TABLE 119. STRYKER CORPORATION: KEY STRATERGIES
TABLE 120. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
TABLE 121. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 122. BOSTON SCIENTIFIC CORPORATION: PRODUCT SEGMENTS
TABLE 123. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 124. BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
TABLE 125. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 126. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 127. ABBOTT LABORATORIES: PRODUCT SEGMENTS
TABLE 128. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 129. ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 130. LIVANOVA PLC: KEY EXECUTIVES
TABLE 131. LIVANOVA PLC: COMPANY SNAPSHOT
TABLE 132. LIVANOVA PLC: PRODUCT SEGMENTS
TABLE 133. LIVANOVA PLC: PRODUCT PORTFOLIO
TABLE 134. LIVANOVA PLC: KEY STRATERGIES
TABLE 135. ZIMMER BIOMET HOLDING INC.: KEY EXECUTIVES
TABLE 136. ZIMMER BIOMET HOLDING INC.: COMPANY SNAPSHOT
TABLE 137. ZIMMER BIOMET HOLDING INC.: PRODUCT SEGMENTS
TABLE 138. ZIMMER BIOMET HOLDING INC.: PRODUCT PORTFOLIO
TABLE 139. ZIMMER BIOMET HOLDING INC.: KEY STRATERGIES
TABLE 140. JOHNSON & JOHNSON: KEY EXECUTIVES
TABLE 141. JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 142. JOHNSON & JOHNSON: PRODUCT SEGMENTS
TABLE 143. JOHNSON & JOHNSON: PRODUCT PORTFOLIO
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
